Navigation Links
SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CANACCORD ADAMS 28TH ANNUAL GLOBAL GROWTH CONFERENCE
Date:8/8/2008

e SA, and Solae. Nestle is currently marketing products that contain one of Senomyx's flavor ingredients. For more information, please visit http://www.senomyx.com

Contact:

Gwen Rosenberg

Senomyx, Inc.

Vice President, Investor Relations & Corporate Communications

858-646-8369

gwen.rosenberg@senomyx.com


'/>"/>
SOURCE Senomyx, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. SENOMYX ANNOUNCES INITIATION OF DEVELOPMENT ACTIVITIES FOR NEW SUCROSE ENHANCER
2. SENOMYX ANNOUNCES EXTENSION OF DISCOVERY AND DEVELOPMENT COLLABORATION WITH CADBURY PLC
3. Senomyx Announces Conclusion of Discovery and Development Collaboration With Kraft Foods Global, Inc.
4. Interleukin Genetics Announces Conference Call and Webcast to Discuss Second Quarter 2008 Business Results
5. Advanced Life Sciences To Host 2008 Second Quarter Financial Results Conference Call and Webcast
6. Orexigen(R) Therapeutics Schedules Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2008
7. Reminder: Webcast Alert: Transgenomic Inc. Announces Second Quarter 2008 Earnings Release Conference Call Webcast
8. Telik Announces 2008 Second Quarter Financial Release, Conference Call and Webcast
9. Medivation Announces Second Quarter 2008 Teleconference and Webcast on August 11, 2008
10. deCODE genetics Announces Webcast of Conference Call to Discuss Second Quarter 2008 Financial Results
11. Webcast Alert: Transgenomic Inc. Announces Second Quarter 2008 Earnings Release Conference Call Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... BRIARCLIFF MANOR, N.Y., Dec. 15 On ... the International Society for Medical Publication Professionals (ISMPP) ... Physicians in London, UK. More than 100 attendees ... new forum for publication professionals, editors, publishers, medical ... world of medical publications and the impact of ...
(Date:12/14/2009)... Calif., Dec. 14 Array BioPharma Inc. ... AMGN ) today announced that they entered into ... Array,s small-molecule glucokinase activator program, including ARRY-403, currently ... in patients with Type 2 diabetes. ... will receive an upfront payment of $60 million ...
(Date:12/14/2009)... The third edition of Infusion Nursing: ... by the Infusion Nurses Society (INS), includes Totect(®), ... Anthracyclines are a group of chemotherapy medications including ... used in the treatment of various types of ... According to the INS publication: "In September 2007, ...
(Date:12/14/2009)... 14 Decision Resources, one of the ... and healthcare issues, finds that, owing to the ... drug market will increase more than sevenfold from ... 2018 in the United States, France, Germany, Italy, ... new Pharmacor report entitled Atrial Fibrillation ...
Breaking Biology Technology:Announcing ISMPP EU 2010 - the First European Meeting of the International Society for Medical Publication Professionals, Royal College of Physicians, London, UK, January 20, 2010 2Array BioPharma and Amgen Partner in Type 2 Diabetes 2Array BioPharma and Amgen Partner in Type 2 Diabetes 3Array BioPharma and Amgen Partner in Type 2 Diabetes 4Array BioPharma and Amgen Partner in Type 2 Diabetes 5Array BioPharma and Amgen Partner in Type 2 Diabetes 6Array BioPharma and Amgen Partner in Type 2 Diabetes 7Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2
... TELK ) announced that company management will provide ... Biotechnology and Medical,Technology Conference in New York City on ... a.m. Pacific time). A live and archived webcast of,the ... ., Telik, Inc. of Palo Alto, CA, is ...
... Boston Scientific,Corporation (NYSE: BSX ) is scheduled to ... held June 9-12 in Dana Point,CA., Jim Tobin, ... which will be followed by a 25-minute question and,answer ... a.m.,PT., A live webcast of Mr. Tobin,s remarks ...
... - Oncolytics Biotech Inc.,("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today ... Phase II clinical trial using intravenous,administration of REOLYSIN(R) ... advanced head and neck cancers. The principal,investigator is ... Research,and The Royal Marsden NHS Foundation Trust., ...
Other Biology Technology:Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Phase II Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin 2
(Date:12/14/2009)... in a freeze-tolerant Alaska beetle able to survive temperatures ... biological antifreezes that contain protein, this new molecule, called ... of a sugar and a fatty acid and may ... , "The most exciting part of this discovery ... of antifreeze that may work in a different location ...
(Date:12/14/2009)... comprehensive study to date of the proteins in a ... important clues to how similar regeneration could be induced ... Science at Indiana University-Purdue University Indianapolis and colleagues investigated ... axolotls, a type of salamander that has the unique ... amputation, with the hope that this knowledge will contribute ...
(Date:12/14/2009)... Nations Framework Convention on Climate Change taking place ... ,Bend the Trend, event on Sunday evening to ... the screening of the new ,Environmental Atlas of ... joint project of the European Environment Agency (EEA), ... a series of short films showing the significance ...
Breaking Biology News(10 mins):Scientists isolate new antifreeze molecule in Alaska beetle 2IUPUI researchers tackle protein mechanisms behind limb regeneration 2'Environmental Atlas of Europe' unveiled at COP15 2HBA X Ceuticals Conference Explores The Emerging Market of Cosmeceuticals and Nutraceuticals 53109 1HBA X Ceuticals Conference Explores The Emerging Market of Cosmeceuticals and Nutraceuticals 53109 2HBA X Ceuticals Conference Explores The Emerging Market of Cosmeceuticals and Nutraceuticals 53109 3Physicians Prompt Care Health Clinic Opens in Orland Park JEWEL OSCO 28R 29 53106 1Physicians Prompt Care Health Clinic Opens in Orland Park JEWEL OSCO 28R 29 53106 2Physicians Prompt Care Health Clinic Opens in Orland Park JEWEL OSCO 28R 29 53106 3Protein Clumps May Appear Years Before Memory Problems 53104 1Protein Clumps May Appear Years Before Memory Problems 53104 2
... March 19, 2009 The 2009 American Society ... to Seattle Times reporters Michael Berens and Ken ... Staphylococcus aureus (MRSA) in Washington State hospitals. ... role in containing the spread of epidemics such ...
... 28, the U.S. National Academy of Sciences will hold its ... elected. Election results will be available online at noon ... can register in advance to receive the list of new ... in the auditorium of the National Academy of Sciences building, ...
... tales has long been disproved by archaeology. , Now, ... heights. In a study that promises fresh and perhaps personal ... a team or researchers from the University of Wisconsin-Madison is ... of crew members Christopher Columbus left on the island of ...
Other Biology News:Seattle Times reporters win ASM public communications award 2Teeth of Columbus' crew flesh out tale of new world discovery 2Teeth of Columbus' crew flesh out tale of new world discovery 3
... contains the basic components required for the ... and recombinant rat Thymus Chemokine-1 in cell ... sufficient materials to run ELISAs on approximately ... conditions are met: The assay ...
FGF Receptor 1 Antibody...
Immunogen: Purified native p24 from strain IIIB. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Mouse Anti-human CD11b/Mac-1alpha, clone LM2/1, Monoclonal Antibody...
Biology Products: